Ankuo Medicine
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $35M
Investors
- 6
About Ankuo Medicine
Established in 2019 and based in Shanghai, China, Ankuo Medicine is a medicine developer that focuses on the development and research of oncology supportive care. Ankuo Medicine's drug candidate product portfolio development aims to solve the skin toxicity caused by cancer therapy. OQL011 is a topical ointment for the treatment of moderate to severe hand-foot-skin reaction (HFSR). It is currently undergoing a multi-center, randomized, phase 2 clinical trial in the United States. In addition, Ankuo Medicine is developing two other tumor dermatological drugs. In addition to the oncology dermatology product portfolio, the company has also developed other targeted cancer support care agents aimed at addressing the gastrointestinal and bone marrow toxicity caused by chemotherapy, HER2/EGFR targeted cancer therapy and immuno-oncology agents. The company generates revenue through the sales of its oncology drugs. In the future, the company will advance the ongoing phase 2 clinical trials of the lead compound OQL011, and a number of other targeted cancer support care plans that are expected to enter different stages of clinical development.
Who invested in Ankuo Medicine
6 investors across 2 rounds
See all investors in Ankuo Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ankuo Medicine
Who invested in Ankuo Medicine?
Ankuo Medicine has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ankuo Medicine raised?
Ankuo Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ankuo Medicine last raise money?
Ankuo Medicine's most recent round on record is a Series A, in Apr 2021.
What does Ankuo Medicine do?
Established in 2019 and based in Shanghai, China, Ankuo Medicine is a medicine developer that focuses on the development and research of oncology supportive care.
Where is Ankuo Medicine headquartered?
Ankuo Medicine is headquartered in Shanghai, China.
Which VCs invest in companies like Ankuo Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Ankuo Medicine's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Ankuo Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.